IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Strides Pharma Science

NSE:STAR · ISIN INE939A01011

Close
₹1,060
29 Jul 2026
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Strides Pharma Science

Ratings & risks

Credit signals

Rating-action history

Agency evidence
CARE Ratings Limited rating actionCARE Ratings Limited · PDF preserved by IndiaTicker
Archived PDF
CARE Ratings Limited rating actionCARE Ratings Limited · PDF preserved by IndiaTicker
Archived PDF
CARE Ratings Limited rating actionCARE Ratings Limited · PDF preserved by IndiaTicker
Archived PDF
CARE Ratings Limited rating actionCARE Ratings Limited · PDF preserved by IndiaTicker
Archived PDF
ICRA Limited · Strides Pharma Science Limited; Ratings withdrawnICRA Limited · discovered
Agency source
CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source
ICRA Limited · Strides Pharma Science Limited: Ratings reaffirmed; Outlook revised to StableICRA Limited · discovered
Agency source
ICRA Limited · Strides Pharma Science Limited: Update on material eventICRA Limited · discovered
Agency source
ICRA Limited · Strides Pharma Science Limited: Long-term rating downgraded; short-term rating reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Strides Pharma Science Limited: Ratings downgraded; outlook revised to Negative from StableICRA Limited · discovered
Agency source
ICRA Limited · Strides Pharma Science Limited – Update on material eventICRA Limited · discovered
Agency source
ICRA Limited · Strides Pharma Science Limited – Update on material eventICRA Limited · discovered
Agency source
ICRA Limited · Strides Pharma Science Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Strides Pharma Science Limited: Ratings reaffirmed and removed from watch with developing implicationsICRA Limited · discovered
Agency source
ICRA Limited · Strides Pharma Science Limited: Ratings of [ICRA]A+/[ICRA]A1 placed on watch with developing implicationsICRA Limited · discovered
Agency source
ICRA Limited · Strides Shasun Limited: Rating reaffirmed and Negative outlook assigned; ratings removed from watch with developing implicationsICRA Limited · discovered
Agency source
ICRA Limited · Strides Shasun Limited: Update on Material EventICRA Limited · discovered
Agency source
ICRA Limited · Strides Shasun Limited: Long term rating reaffirmed at [ICRA]A+ and short-term rating revised to [ICRA]A1; continues to be on watch with developing implicationsICRA Limited · discovered
Agency source
ICRA Limited · ICRA assigns [ICRA]A+ rating to enhanced term loan facilities of Strides Shasun Limited; ratings continue to be on watch with developing implicationsICRA Limited · discovered
Agency source
ICRA Limited · ICRA reaffirms the [ICRA]A+ / A1+ ratings outstanding on the bank facilities of Strides Shasun Limited; ratings continue to be on watch with developing implicationsICRA Limited · discovered
Agency source
ICRA Limited · ICRA places ratings for Strides Shasun Limited on 'rating watch with developing implications'ICRA Limited · discovered
Agency source
ICRA Limited · Rating of [ICRA]A1+ assigned to the enhanced bank facilities of Strides Shasun LimitedICRA Limited · discovered
Agency source
Risk research framework

Questions to test against evidence

Analyst review
Operating deterioration

Track sector-specific operating metrics and reconcile them across reporting periods.

High
Funding and liquidity

Review debt maturity, repricing, liquidity and rating commentary where relevant.

High
Execution versus guidance

Compare management statements with subsequent reported delivery.

Medium
Governance and key-person change

Connect management transitions, related parties and auditor observations.

Medium